Streetbeat News

Analyst Ratings

FCNCA

Wedbush analyst David Chiaverini has downgraded First Citizens BancShares (NASDAQ:FCNCA) from Outperform to Neutral and reduced the price target from $2450 to $2150.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:50 am

FHN

Wedbush analyst David Chiaverini has downgraded First Horizon (NYSE:FHN) from Outperform to Neutral and reduced the price target from $20 to $17.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:39 am

RF

Wedbush analyst David Chiaverini has upgraded Regions Financial (NYSE:RF) from Neutral to Outperform and increased the price target from $23 to $28.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:38 am

RUN

Morgan Stanley analyst Stephen Byrd maintains an Overweight rating on Sunrun (NASDAQ:RUN) with a $35 price target.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:31 am

FHTX

Morgan Stanley analyst Vikram Purohit maintains an Equal-Weight rating on Foghorn Therapeutics (NASDAQ:FHTX) and raises the price target from $6 to $9.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:29 am

CART

Morgan Stanley analyst Brian Nowak maintains an Equal-Weight rating on Maplebear (NASDAQ:CART) but lowers the price target from $45 to $41.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:28 am

CUBI

Wedbush analyst David Chiaverini has downgraded Customers Bancorp (NYSE:CUBI) from Outperform to Neutral and reduced the price target from $79 to $53.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:28 am

PB

Wedbush analyst David Chiaverini has upgraded Prosperity Bancshares (NYSE:PB) from Neutral to Outperform and increased the price target from $75 to $90.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:25 am

COLB

Wedbush analyst David Chiaverini has upgraded Columbia Banking System (NASDAQ:COLB) from Neutral to Outperform and increased the price target from $28 to $31.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:23 am

CMA

Wedbush analyst David Chiaverini has upgraded Comerica (NYSE:CMA) from Neutral to Outperform and increased the price target from $52 to $75.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:17 am